Effective Symptom Control for Better Breathing

Aerivio Spiromax is a combination inhaler designed to manage asthma and chronic obstructive pulmonary disease (COPD). By combining a corticosteroid (fluticasone) with a long-acting bronchodilator (salmeterol), it reduces inflammation and keeps airways open, ensuring better long-term respiratory control.

Prevents Asthma Attacks and COPD Flare-Ups

This inhaler is not just for symptom relief—it works proactively to prevent breathing difficulties before they start. With regular use, Aerivio Spiromax helps reduce the frequency and severity of asthma attacks and COPD exacerbations, keeping you active and in control.

Easy-to-Use, Breath-Activated Inhaler

Aerivio Spiromax features a breath-activated design, making it simple to use without the need for coordination. Its compact and portable inhaler ensures convenient daily dosing, helping you manage your respiratory health with ease.